Home・Aktien・AbCellera Biologics Inc
Search

AbCellera Biologics Inc

Geschlossen

BrancheGesundheitswesen

6.4 4.23

Starkes Kaufsignal

Kursupdate 7. Aug. 2026, 14:10 UTC

BuySell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.71

Max

6.55

Schlüsselkennzahlen

By Trading Economics

Einkommen

-34M

-43M

Verkäufe

-37M

8.3M

EPS

-0.14

Gewinnspanne

-519.122

Angestellte

562

EBITDA

-23M

-41M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+82.94% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

178M

1.8B

Vorheriger Eröffnungskurs

2.17

Vorheriger Schlusskurs

6.4

Nachrichtenstimmung

By Acuity

47%

53%

159 / 340 Ranking in Healthcare

AbCellera Biologics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Aug. 2026, 23:06 UTC

Abcellera Biologics Inc. shares are lower in after-market trading, despite earlier reaching a session high and remaining above the 20-day moving average.

Lesen

5. Aug. 2026, 23:02 UTC

Social Media
News

Abcellera Biologics shares are lower in after-market hours following disappointing Q2 results, with an EPS of -$0.18 and revenue of $4.1 million.

Lesen

3. Aug. 2026, 19:36 UTC

Correlated Moves

Abcellera Biologics Inc shares are higher as market sentiment improves following President Trump's cancellation of a military strike on Iran.

Lesen

31. Juli 2026, 19:33 UTC

Correlated Moves
Social Media

Abcellera Biologics Inc is declining during Friday's session, reflecting broader biotech sector weakness amid rising yields and inflation concerns.

Lesen

30. Juli 2026, 23:41 UTC

Correlated Moves

Abcellera Biologics shares are lower in after-market trading, reflecting broader market volatility following the Federal Reserve's decision to maintain interest rates.

Lesen

29. Juli 2026, 23:51 UTC

Abcellera Biologics Inc. shares were roughly flat in after-market hours, with no specific news identified. The stock is down significantly from last month's close.

Lesen

28. Juli 2026, 19:41 UTC

News

Abcellera Biologics is rising, driven by gains in the Life Sciences Tools & Services sector and positive trends in the antibody therapeutics market.

Lesen

27. Juli 2026, 19:46 UTC

Correlated Moves

Abcellera Biologics Inc shares are higher, reflecting a modest increase since Friday's close. Broader market gains may influence sentiment in life sciences.

Lesen

24. Juli 2026, 23:46 UTC

Abcellera Biologics Inc shares are higher in after-market hours, showing resilience despite recent challenges in the bond market and declining prices.

Lesen

22. Juli 2026, 20:06 UTC

Abcellera Biologics Inc shares are lower today, reflecting broader market trends amid uncertainty ahead of the Federal Reserve meeting on July 29.

Lesen

21. Juli 2026, 23:06 UTC

Correlated Moves

Abcellera Biologics shares higher in after-market trading, maintaining strong performance since Tuesday's close, despite being below its 20-day moving average.

Lesen

20. Juli 2026, 23:16 UTC

Abcellera Biologics Inc. shares are roughly flat in after-market trading, remaining about 16.33% below their 20-day moving average.

Lesen

Peer-Vergleich

Kursveränderung

AbCellera Biologics Inc Prognose

Kursziel

By TipRanks

82.94% Vorteil

12-Monats-Prognose

Durchschnitt 10.83 USD  82.94%

Hoch 13 USD

Tief 7 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AbCellera Biologics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

7

Buy

0

Halten

0

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für AbCellera Biologics Inc – Dist abgegeben haben.

Stimmung

By Acuity

159 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AbCellera Biologics Inc

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Andere Aktien aus dem Sektor

JNJ

Johnson and Johnson

257.05

↓-0.22%

ABBV

AbbVie Inc

243.68

↓-0.99%

UNH

UnitedHealth Group Inc

403.72

↓-2.25%

NVS

Novartis AG

154.08

↓-0.05%

AZN

AstraZeneca PLC

160.97

↓-0.25%
help-icon Live chat